Clinical impact of altered immunoglobulin levels in Henoch-Schönlein purpura
- PMID: 19400827
- DOI: 10.1111/j.1442-200X.2008.02762.x
Clinical impact of altered immunoglobulin levels in Henoch-Schönlein purpura
Abstract
Background: The aim of the present study was the identification of immunological features, present at the time of diagnosis, that would predict the severity of Henoch-Schönlein purpura and its outcome.
Methods: A cohort study was carried out in a tertiary pediatric hospital of 69 children with Henoch-Schönlein purpura, in whom serum complement components C3, C4 and IgA, IgM, IgG were repeatedly determined.
Results: During the acute phase of the disease in 54/69 patients (78.3%) immunological imbalances were observed. In 24/54 cases (44.4%) certain complications involving the kidneys and the gastrointestinal tract were noted as opposed to in 3/15 children (20%) without immunologic abnormalities. In 50/69 children (72.5%), elevated serum IgA was detected and 16 of them (32%) developed renal involvement while only 1/19 children (5.3%) with normal IgA concentration had renal involvement. Considering separately the group of 9/69 children (13%) with increased IgM and those with normal IgM levels (53/69; 76.8%), irrespective of IgA and IgG concentration, we found a comparable percentage of children who had both renal and intestinal involvement without, however, developing severe complications, which were exclusively seen in patients with increased IgA (5/7 children) and reduced IgM levels. Serum C3 fraction was elevated in 26 children (37.7%) and in 73% of cases it was associated with increased serum IgA values.
Conclusion: Renal involvement was seen in 32% of children with increased IgA values. Most importantly, elevated IgA concentration along with reduced IgM levels was associated with higher prevalence of severe complications.
Similar articles
-
Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.Clin Biochem. 2018 Feb;52:167-170. doi: 10.1016/j.clinbiochem.2017.11.006. Epub 2017 Nov 10. Clin Biochem. 2018. PMID: 29129626
-
Immunologic changes in children with Henoch-Schonlein purpura in the acute stage.Chin Med J (Engl). 1989 Jul;102(7):533-6. Chin Med J (Engl). 1989. PMID: 2517070
-
Characteristics of immune function in the acute phase of Henoch-Schönlein purpura.Clin Rheumatol. 2021 Sep;40(9):3711-3716. doi: 10.1007/s10067-021-05707-6. Epub 2021 Mar 29. Clin Rheumatol. 2021. PMID: 33782751
-
Electron-dense subepithelial glomerular deposits in Henoch-Schönlein purpura syndrome.Arch Pathol Lab Med. 1979 Oct;103(11):595-8. Arch Pathol Lab Med. 1979. PMID: 384959
-
Quantitation of red cell-bound immunoprotein.Transfusion. 1998 Aug;38(8):782-95. doi: 10.1046/j.1537-2995.1998.38898375519.x. Transfusion. 1998. PMID: 9709788 Review. No abstract available.
Cited by
-
Expansion of Circulating T Follicular Helper Cells in Children with Acute Henoch-Schönlein Purpura.J Immunol Res. 2015;2015:742535. doi: 10.1155/2015/742535. Epub 2015 Sep 28. J Immunol Res. 2015. PMID: 26491701 Free PMC article.
-
A single-center analysis of Henoch-Schonlein purpura nephritis with nephrotic proteinuria in children.Pediatr Rheumatol Online J. 2017 Mar 4;15(1):15. doi: 10.1186/s12969-017-0146-4. Pediatr Rheumatol Online J. 2017. PMID: 28257644 Free PMC article.
-
IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.Front Immunol. 2022 Oct 3;13:921864. doi: 10.3389/fimmu.2022.921864. eCollection 2022. Front Immunol. 2022. PMID: 36263029 Free PMC article. Review.
-
Clinical features and risk factors of abdominal IgA vasculitis in adults.Clin Rheumatol. 2025 Sep;44(9):3639-3648. doi: 10.1007/s10067-025-07569-8. Epub 2025 Jul 11. Clin Rheumatol. 2025. PMID: 40646367
-
Henoch-schonlein purpura-a case report and review of the literature.Gastroenterol Res Pract. 2010;2010:597648. doi: 10.1155/2010/597648. Epub 2010 May 23. Gastroenterol Res Pract. 2010. PMID: 20508739 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous